It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ketamine is a dissociative anesthetic that induces a shift in global consciousness states and related brain dynamics. Portable low-density EEG systems could be used to monitor these effects. However, previous evidence is almost null and lacks adequate methods to address global dynamics with a small number of electrodes. This study delves into brain high-order interactions (HOI) to explore the effects of ketamine using portable EEG. In a double-blinded cross-over design, 30 male adults (mean age = 25.57, SD = 3.74) were administered racemic ketamine and compared against saline infusion as a control. Both task-driven (auditory oddball paradigm) and resting-state EEG were recorded. HOI were computed using advanced multivariate information theory tools, allowing us to quantify nonlinear statistical dependencies between all possible electrode combinations. Ketamine induced an increase in redundancy in brain dynamics (copies of the same information that can be retrieved from 3 or more electrodes), most significantly in the alpha frequency band. Redundancy was more evident during resting state, associated with a shift in conscious states towards more dissociative tendencies. Furthermore, in the task-driven context (auditory oddball), the impact of ketamine on redundancy was more significant for predictable (standard stimuli) compared to deviant ones. Finally, associations were observed between ketamine’s HOI and experiences of derealization. Ketamine appears to increase redundancy and HOI across psychometric measures, suggesting these effects are correlated with alterations in consciousness towards dissociation. In comparisons with event-related potential (ERP) or standard functional connectivity metrics, HOI represent an innovative method to combine all signal spatial interactions obtained from low-density dry EEG in drug interventions, as it is the only approach that exploits all possible combinations between electrodes. This research emphasizes the potential of complexity measures coupled with portable EEG devices in monitoring shifts in consciousness, especially when paired with low-density configurations, paving the way for better understanding and monitoring of pharmacological-induced changes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Universidad Adolfo Ibañez, Latin American Brain Health Institute, Santiago de Chile, Chile (GRID:grid.440617.0) (ISNI:0000 0001 2162 5606); CNRS, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, Paris, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282)
2 Cumulus Neuroscience Ltd, Dublin, Ireland (GRID:grid.4444.0)
3 Universidad San Sebastián, Escuela de Fonoaudiología, Facultad de Odontología y Ciencias de la Rehabilitación, Santiago, Chile (GRID:grid.442215.4) (ISNI:0000 0001 2227 4297)
4 Jena University Hospital, Department of Psychiatry and Psychotherapy, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224)
5 Jena University Hospital, Department of Psychiatry and Psychotherapy, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224); partner site Halle-Jena-Magdeburg, German Center for Mental Health (DZPG), Jena, Germany (GRID:grid.275559.9)
6 Takeda Pharmaceuticals, Neuroscience Drug Discovery Unit, Cambridge, USA (GRID:grid.419849.9) (ISNI:0000 0004 0447 7762)
7 Cumulus Neuroscience Ltd, Dublin, Ireland (GRID:grid.419849.9)
8 Universidad Adolfo Ibañez, Latin American Brain Health Institute, Santiago de Chile, Chile (GRID:grid.440617.0) (ISNI:0000 0001 2162 5606); UCSF and Trinity College Dublin, Global Brain Health Institute, Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705)